Skip to main content

Headlines

Viridian Therapeutics Breaks Above 200-Day Moving Average - Bullish for VRDN
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
First Week of August 16th Options Trading For Cerevel Therapeutics Holdings (CERE)
posted:
by: Nasdaq Options
#channels:: #All, #Business, #Stocks, #Nasdaq, #Options, #StockOptions, #NasdaqOptions
Larimar Therapeutics Reports Positive Data From Nomlabofusp Phase 2 Study In FA Patients
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
1 of Sarepta Therapeutics' Competitors Just Got Hammered. Will It Help the Stock?
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
CRISPR Therapeutics AG (CRSP) Laps the Stock Market: Here's Why
posted:
by: Nasdaq Stocks
#channels:: #All, #Business, #Stocks, #Nasdaq, #NasdaqStocks
BioXcel Therapeutics Commences $60 Mln Public Offering; Stock Drops
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
First Week of February 16th Options Trading For Soleno Therapeutics (SLNO)
posted:
by: Nasdaq Options
#channels:: #All, #Business, #Stocks, #Nasdaq, #Options, #StockOptions, #NasdaqOptions
RSI Alert: Relay Therapeutics (RLAY) Now Oversold
posted:
by: Nasdaq Stocks
#channels:: #All, #Business, #Stocks, #Nasdaq, #NasdaqStocks
Commit To Purchase Corcept Therapeutics At $18, Earn 34.5% Annualized Using Options
posted:
by: Nasdaq Stocks
#channels:: #All, #Business, #Stocks, #Nasdaq, #NasdaqStocks
Commit To Buy Keros Therapeutics At $50, Earn 18.5% Annualized Using Options
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Fate Therapeutics (FATE) Soars 25.4%: Is Further Upside Left in the Stock?
posted:
by: Nasdaq Stocks
#channels:: #All, #Business, #Stocks, #Nasdaq, #NasdaqStocks
Is CRISPR Therapeutics a Buy in the New Bull Market?
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Commit To Buy Relay Therapeutics At $7.50, Earn 14.5% Annualized Using Options
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Cyclo Therapeutics Gets Notice Of Allowance For Patent Regarding Treatment Of Alzheimer's Disease
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Vera Therapeutics Reaches Analyst Target Price
posted:
by: Nasdaq ETFs
#channels:: #All, #Business, #Nasdaq, #NasdaqETFs, #ETFs, #Stocks